drugset / Trial / NCT02700347
Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Pyrazinamide Plus Allopurinol in Healthy Volunteers
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the bactericidal activity against Mycobacterium tuberculosis of pyrazinamide in combination with allopurinol. Pharmacokinetics (PK) and whole blood bactericidal activity (WBA) will be measured in healthy volunteers following administration of pyrazinamide alone and in combination with allopurinol.
Timeline
- Start
- 2016-02
- Primary completion
- 2016-04
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allopurinol | Small molecule | 100 mg | — |
| Subject | Pyrazinamide | Small molecule | 10 mg/kg | — |
| Subject | Pyrazinamide | Small molecule | 25 mg/kg | — |
| Subject | Pyrazinamide | Small molecule | 35 mg/kg | — |